Skip to main content
Erschienen in: Journal of Cancer Education 2/2018

09.12.2016

Knowledge and Awareness of Colorectal Cancer Early Warning Signs and Risk Factors among University Students in Jordan

verfasst von: Nizar M. Mhaidat, Belal A. Al-husein, Karem H. Alzoubi, Dima I. Hatamleh, Youcef Khader, Sinaa Matalqah, Abla Albsoul

Erschienen in: Journal of Cancer Education | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

In the present study, we aimed to assess the level of awareness regarding CRC warning signs and risk factors among undergraduate students. A cross-sectional survey using standardized questionnaire developed by the Cancer Research Center in the UK was carried out in three different public universities in Jordan including Jordan University of Science and Technology, Yarmouk University, and AL al-Bayt University over a 5-month period. Volunteers were asked about their knowledge regarding CRC symptoms, risk factors, and their behaviors regarding seeking medical advice. Findings revealed that response rate was 80.1%. Vast majority of responders were female (70.9%) and 18.2% of them were studying medical-related specialties. Regarding CRC symptoms, 14.3% of responders experienced poor knowledge, 52.9% have fair knowledge, and 32.8% have good knowledge. Abdominal pain was the most recognized warning signs where 70.8% of responders could recall it. In addition, risk factors awareness was lower than warning signs awareness. About 36.1% of responders have poor knowledge, 47.4% had fair knowledge, and 16.5% had good knowledge. Unhealthy diet was the most recognized risk factor where 32.3% of responders could recall it. Moreover, females were more aware regarding CRC symptoms. Similar findings were obtained for participants who were aged 20 years or more and for those who had previous experience of cancer. Students who were studying medical-related specialties were more aware of both CRC symptoms and risk factors than those who studying other specialties. Furthermore, regarding time to seek medical attention we found that 60.6% of volunteers would seek medical advice within 1 week of noticing CRC symptoms and 12% would seek it within 2 weeks. The mean duration for seeking medical advice was found to be 1.9 weeks. University students’ awareness level of CRC is poor, and therefore, extended attention should be attempted to enhance the awareness of CRC via continuous education programs, lectures, or campaigns to encourage the early detection CRC.
Literatur
1.
Zurück zum Zitat Al-Azri M, Al-Hamedi I, Al-Awisi H, Al-Hinai M, Davidson R (2015) Public awareness of warning signs and symptoms of cancer in Oman: a community-based survey of adults. Asian Pac J Cancer Prev 16(7):2731–2737CrossRefPubMed Al-Azri M, Al-Hamedi I, Al-Awisi H, Al-Hinai M, Davidson R (2015) Public awareness of warning signs and symptoms of cancer in Oman: a community-based survey of adults. Asian Pac J Cancer Prev 16(7):2731–2737CrossRefPubMed
2.
Zurück zum Zitat Al-Azri M, Al-Rasbi K, Al-Hinai M, Davidson R, Al-Maniri A (2014) Awareness of risk factors for cancer among Omani adults—a community based study. Asian Pac J Cancer Prev 15(13):5401–5406CrossRefPubMed Al-Azri M, Al-Rasbi K, Al-Hinai M, Davidson R, Al-Maniri A (2014) Awareness of risk factors for cancer among Omani adults—a community based study. Asian Pac J Cancer Prev 15(13):5401–5406CrossRefPubMed
3.
Zurück zum Zitat Al-Tarawneh M, Khatib S, Arqub K (2010) Cancer incidence in Jordan, 1996-2005. East Mediterr Health J 16(8):837–845PubMed Al-Tarawneh M, Khatib S, Arqub K (2010) Cancer incidence in Jordan, 1996-2005. East Mediterr Health J 16(8):837–845PubMed
4.
Zurück zum Zitat Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK et al (2002) Inherited variants of MYH associated with somatic G:C-- > T:a mutations in colorectal tumors. Nat Genet 30(2):227–232. doi:10.1038/ng828 CrossRefPubMed Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK et al (2002) Inherited variants of MYH associated with somatic G:C-- > T:a mutations in colorectal tumors. Nat Genet 30(2):227–232. doi:10.​1038/​ng828 CrossRefPubMed
5.
Zurück zum Zitat Andersen BL, Cacioppo JT (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 34(Pt 1):33–52CrossRefPubMed Andersen BL, Cacioppo JT (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 34(Pt 1):33–52CrossRefPubMed
6.
Zurück zum Zitat Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, Lloyd A, Ma YP, Dobbins SE, Houlston RS (2015) Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol 33(5):426–432. doi:10.1200/JCO.2014.56.5689 CrossRefPubMed Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, Lloyd A, Ma YP, Dobbins SE, Houlston RS (2015) Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol 33(5):426–432. doi:10.​1200/​JCO.​2014.​56.​5689 CrossRefPubMed
7.
Zurück zum Zitat CLSI (2008b) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne doi: 91100957 [pii] CLSI (2008b) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne doi: 91100957 [pii]
8.
Zurück zum Zitat De Nooijer J, Lechner L, De Vries H (2001) Help-seeking behaviour for cancer symptoms: perceptions of patients and general practitioners. Psychooncology 10(6):469–478CrossRefPubMed De Nooijer J, Lechner L, De Vries H (2001) Help-seeking behaviour for cancer symptoms: perceptions of patients and general practitioners. Psychooncology 10(6):469–478CrossRefPubMed
9.
Zurück zum Zitat Dent OF, Goulston KJ, Tennant CC, Langeluddecke P, Mant A, Chapuis PH, Ward M, Bokey EL (1990) Rectal bleeding. Patient delay in presentation. Dis Colon rectum 33(10):851–857 Dent OF, Goulston KJ, Tennant CC, Langeluddecke P, Mant A, Chapuis PH, Ward M, Bokey EL (1990) Rectal bleeding. Patient delay in presentation. Dis Colon rectum 33(10):851–857
10.
Zurück zum Zitat DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (2011) Coloracta Cancer. In: Davis LE, Sun W, Medina PJ (eds) Pharmacotherapy: a pathophysiologic approach. McGraw-Hill Education, USA DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (2011) Coloracta Cancer. In: Davis LE, Sun W, Medina PJ (eds) Pharmacotherapy: a pathophysiologic approach. McGraw-Hill Education, USA
11.
Zurück zum Zitat Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C et al (2013) Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer 108(2):292–300. doi:10.1038/bjc.2012.542 CrossRefPubMedPubMedCentral Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C et al (2013) Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer 108(2):292–300. doi:10.​1038/​bjc.​2012.​542 CrossRefPubMedPubMedCentral
13.
16.
Zurück zum Zitat Keighley MR, O’Morain C, Giacosa A, Ashorn M, Burroughs A, Crespi M, Delvaux M et al (2004) Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev 13(4):257–262CrossRefPubMed Keighley MR, O’Morain C, Giacosa A, Ashorn M, Burroughs A, Crespi M, Delvaux M et al (2004) Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev 13(4):257–262CrossRefPubMed
18.
Zurück zum Zitat McCaffery K, Wardle J, Waller J (2003) Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med 36(5):525–535CrossRefPubMed McCaffery K, Wardle J, Waller J (2003) Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med 36(5):525–535CrossRefPubMed
23.
Zurück zum Zitat Power E, Miles A, von Wagner C, Robb K, Wardle J (2009) Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncol 5(9):1371–1388. doi:10.2217/fon.09.134 CrossRefPubMed Power E, Miles A, von Wagner C, Robb K, Wardle J (2009) Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncol 5(9):1371–1388. doi:10.​2217/​fon.​09.​134 CrossRefPubMed
26.
Zurück zum Zitat Quaife SL, Forbes LJ, Ramirez AJ, Brain KE, Donnelly C, Simon AE, Wardle J (2014) Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UK. Br J Cancer 110(1):12–18. doi:10.1038/bjc.2013.684 CrossRefPubMed Quaife SL, Forbes LJ, Ramirez AJ, Brain KE, Donnelly C, Simon AE, Wardle J (2014) Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UK. Br J Cancer 110(1):12–18. doi:10.​1038/​bjc.​2013.​684 CrossRefPubMed
27.
31.
Zurück zum Zitat Simon AE, Waller J, Robb K, Wardle J (2010) Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomark Prev 19(9):2272–2277. doi:10.1158/1055-9965.EPI-10-0219 CrossRef Simon AE, Waller J, Robb K, Wardle J (2010) Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomark Prev 19(9):2272–2277. doi:10.​1158/​1055-9965.​EPI-10-0219 CrossRef
33.
Zurück zum Zitat Su TT, Goh JY, Tan J, Muhaimah AR, Pigeneswaren Y, Khairun NS, Normazidah AW, Tharisini DK, Majid HA (2013) Level of colorectal cancer awareness: a cross sectional exploratory study among multi-ethnic rural population in Malaysia. BMC Cancer 13:376. doi:10.1186/1471-2407-13-376 CrossRefPubMedPubMedCentral Su TT, Goh JY, Tan J, Muhaimah AR, Pigeneswaren Y, Khairun NS, Normazidah AW, Tharisini DK, Majid HA (2013) Level of colorectal cancer awareness: a cross sectional exploratory study among multi-ethnic rural population in Malaysia. BMC Cancer 13:376. doi:10.​1186/​1471-2407-13-376 CrossRefPubMedPubMedCentral
34.
35.
Zurück zum Zitat Yardley C, Glover C, Allen-Mersh TG (2000) Demographic factors associated with knowledge of colorectal cancer symptoms in a UK population-based survey. Ann R Coll Surg Engl 82(3):205–209PubMedPubMedCentral Yardley C, Glover C, Allen-Mersh TG (2000) Demographic factors associated with knowledge of colorectal cancer symptoms in a UK population-based survey. Ann R Coll Surg Engl 82(3):205–209PubMedPubMedCentral
Metadaten
Titel
Knowledge and Awareness of Colorectal Cancer Early Warning Signs and Risk Factors among University Students in Jordan
verfasst von
Nizar M. Mhaidat
Belal A. Al-husein
Karem H. Alzoubi
Dima I. Hatamleh
Youcef Khader
Sinaa Matalqah
Abla Albsoul
Publikationsdatum
09.12.2016
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2018
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1142-y

Weitere Artikel der Ausgabe 2/2018

Journal of Cancer Education 2/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.